Abstract:Background: The hyaluronic acid (HA) dermal filler, Juvederm (R) Ultra, which employs Hylacross (R) technology, produces a gel with a smooth consistency and has demonstrated effectiveness in correcting nasolabial folds (NLFs) in Caucasian populations.Objective:To evaluate the safety and effectiveness of Juvederm Ultra vs Restylane (R) for the correction of moderate NLFs in Chinese subjects.Methods: In this double-blind randomized study, adult Chinese subjects with moderate NLFs received Juvederm Ultra (24 mg/mL) in 1 NLF and Restylane injectable gel (20 mg/mL) in the other NLF. NLFs were evaluated using the validated 5-point photonumeric Allergan NLF Severity Scale (NLFSS); scores ranged from 0 ("no wrinkle") to 4 ("very deep wrinkle"). Response was defined as >= 1-point improvement at 6 months. Investigator-assessed responder rate (primary outcome), NLF mean improvement, and subject-assessed responder rate and preference were assessed.Results: Among the 104 subjects who completed the study, median initial volumes (mL) were 0.8 (range, 0.2-1.4) for Juvederm Ultra and 0.8 (0.3-1.5) for Restylane; median touch-up volumes were 0.3 (0.1-0.5) and 0.3 (0.1-0.5), respectively. At 6 months, investigator assessed responder rates were 873% for both products, indicating that Juvederm Ultra was noninferior to Restylane; mean improvement in NLFSS scores from baseline was 1.0 for both products. At 6 months, Juvederm Ultra and Restylane subject-assessed responder rates were 86.3% and 79.4%, respectively, and mean improvement in NLFSS scores from baseline was 1.2 and 1.0, respectively. Among subjects who expressed a preference, 57.9% preferred Juvederm Ultra. For both products, the most commonly reported treatment site responses were swelling, firmness, and tenderness; treatment site responses were generally mild or moderate in severity. Juvederm Ultra had fewer severe responses than Restylane.Conclusions: Juvederm Ultra is noninferior to Restylane and is a safe and effective treatment for correcting moderate NLFs in Chinese subjects.

Safe and Effective Lip Enhancement with VYC-15L in Chinese Adults

VYC-20L is Safe and Effective for Improving Volume and Aesthetic Appearance of the Nose in Chinese Adults

Juvéderm Volift (VYC-17.5L), a Hyaluronic Acid Filler with Lidocaine, is Safe and Effective for Correcting Nasolabial Folds in Chinese Subjects

Restoring long‐lasting midface volume in the Asian face with a hyaluronic acid filler: A randomized controlled multicenter study

A Randomized, Controlled, Multicenter Study Of Juvederm Voluma For Enhancement Of Malar Volume In Chinese Subjects

Lifting the Midface Using a Hyaluronic Acid Filler with Lidocaine: A Randomized Multi‐center Study in a Chinese Population

Safety and Effectiveness of Hyaluronic Acid Filler, VYC-20L, via Cannula for Cheek Augmentation: A Randomized, Single-Blind, Controlled Study

Effectiveness of Volbella (VYC-15L) for Infraorbital Hollowing: Patient-Reported Outcomes From a Prospective, Multicenter, Single-Blind, Randomized, Controlled Study

Long-term Safety and Effectiveness of Hyaluronic Acid Fillers Correcting Nasolabial Folds in Chinese Patients

Volumizing Hyaluronic Acid Filler for Midface Volume Deficit: 2‐Year Results from a Pivotal Single‐Blind Randomized Controlled Study

A prospective open-label study for treatment of infraorbital hollows using a volumizing hyaluronic acid filler

Safety and Effectiveness of Hyaluronic Acid Injectable Gel in Correcting Moderate Nasolabial Folds in Chinese Subjects.

A Prospective, Multicenter, Single-Blind, Randomized, Controlled Study of VYC-15L, a Hyaluronic Acid Filler, in Adults for Correction of Infraorbital Hollowing

Hyaluronic Acid Filler VYC-25L for Jawline Restoration Yields High Satisfaction, Improved Jawline Measurements, and Sustained Effectiveness Across Skin Types, Age, and Gender for up to 12 Months

Structural Aesthetic Treatment With the Hyaluronic Acid Filler VYC‐25L: Global Expert Considerations for Safe and Effective Long‐Term Outcomes

An Evaluation of VYC‐17.5L for the Treatment of Marionette Lines: A Prospective, Open‐Label, Postmarketing Study

Single-center, prospective comparison of calcium hydroxylapatite and Vycross-20L in midface rejuvenation: Efficacy and patient-perceived value

Duration of Effect by Injection Volume and Facial Subregion for a Volumizing Hyaluronic Acid Filler in Treating Midface Volume Deficit

Safe and Effective Restoration of Jawline Definition With Hyaluronic Acid Injectable Gel VYC-25L: Results From a Randomized Controlled Study

"A Multi-center, randomized, double blinded, comparative study of two hyaluronic acid fillers for temporary restoration of mid-face volume in Asians"